학술논문
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceaein France
Document Type
Article
Author
Source
Infectious Diseases Now; October 2022, Vol. 52 Issue: 7 p396-402, 7p
Subject
Language
ISSN
26669919
Abstract
•Nationwide study, using data from Point Prevalance studies in acute care hospitals.•Decrease in carbapenem and aminoglycoside use between 2012 and 2017, in patients with an ESBL-producing EnterobacteriaceaeHAI:•Treatment durations remain longer than recommended.•Results can serve to direct future efforts in antimicrobial stewardship.